Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial ScienceDirect Development of Cagrilintide, a Long Acting Amylin Analogue Journal of Medicinal Chemistry Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial ScienceDirect Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3 eBioMedicine Eloralintide, a selective, longacting amylin receptor agonist for treatment of obesity: Phase 1 proof of concept Bhattachar 2026 Diabetes, Obesity and Metabolism Wiley Online Library Discovery of BGM1812, a Novel Dual Amylin and Calcitonin Receptor Agonist for Obesity Treatment Journal of Medicinal Chemistry